• SENSEX 74,781.76
    -120.83 (--0.16%)
  • BANKNIFTY 56,606.55
    134.60 (+0.24%)
  • Molbio Diagnosti
    1,393.10 925.80(%)
  • Pine Labs
    206.10 283.70(%)
  • Larsen & Toubro
    3,880.55 3,288.65(%)
  • HDFC Bank
    708.90 1,020.35(%)
  • Power Grid Corpn
    268.30 250.05(%)
  • ESDS Software
    1,716.35 1,716.35(%)
  • Trent
    2,815.00 3,497.35(%)
  • Raymond
    1,024.00 1,024.00(%)
  • Metro Brands
    924.20 883.40(%)
  • Reliance Industries
    1,253.20 1,250.55(%)
  • Billionbrains
    200.90 227.00(%)
  • Ather Energy
    1,615.00 530.65(%)
  • One 97
    1,829.50 1,829.50(%)
  • Hind.Aeronautics
    4,861.65 3,479.20(%)
  • UPL
    567.25 558.00(%)
  • HDFC Life Insur.
    531.15 796.60(%)
  • Bajaj Finance
    1,015.40 788.40(%)
  • Lodha Developers
    1,076.00 650.85(%)
  • Dhoot Transmission
    1,727.35 1,727.35(%)
  • Britannia Inds.
    4,946.05 4,946.05(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Kabra Drugs Ltd Trading

  • Indian Private
  • BSE Code : 2908.0
  • ISIN : INE323K01017
20.65 1 (2.53%)
  • As on 14 Sep 2026 (EOD)

  • Today’s Low

    19.30

  • Today’s High

    21.25

  • Open

    20.14

  • Perv Close

    20.14

  • 52W Low

    15.50

  • 52W High

    35.52

Key Indicators

  • P/E(TTM)

    6.45

  • Mar.Cap (₹Cr.)

    48.96

  • Div & Yield %

    0.00

  • Book Value(₹)

    12.49

  • Debt-Equity Ratio

    2.53

  • AGM Date

    11-Sep-2026

  • EPS

    3.20

  • P/E Ratio

    6.45

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    48.96

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    23.71

  • BV (₹)

    12.50

  • Sales( ₹ in Cr.)

    92.74

  • NP (in Cr.)

    4.96

  • NP Var(%)

    557.0

  • Div%

    0.0

  • CPS (₹)

    2.10

  • EPS (₹)

    2.10

  • Traded Value (₹ in Lakhs)

    48.96

  • 52 Week High

    35.52

  • 52 Week Low

    15.50

  • Price BSE

    21.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    48.96

  • P/C Ratio

    9.90

  • P/E Ratio

    10.00

  • Price Vs.BV

    2.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 0.00 0.00 0.00 0.00 0.00 0.00
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 0.00 0.00 0.00 0.00 0.00 0.00
Other Income 0.64 0.00 0.01 0.00 0.00 0.02
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 0.64 0.00 0.01 0.00 0.00 0.02
EXPENDITURE :            
Raw Materials 0.00 0.00 0.00 0.00 0.00 0.00
Power and Fuel Cost 0.00 0.00 0.00 0.00 0.00 0.00
Employee Cost 0.69 0.40 0.23 0.09 0.05 0.00
Other Manufacturing Expenses 0.00 0.00 0.00 0.00 0.00 0.00
Selling and Administration Expenses 0.94 0.30 0.09 0.08 0.10 0.05
Miscellaneous Expenses 0.08 0.03 0.02 0.01 0.00 0.00
Employee Benefit Expenses 0.69 0.40 0.23 0.09 0.05 0.00
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1.72 0.74 0.34 0.18 0.15 0.05
Operating Profit -1.08 -0.74 -0.34 -0.18 -0.15 -0.03
Interest 0.00 0.00 0.00 0.00 0.00 0.00
Gross Profit -1.08 -0.74 -0.34 -0.18 -0.15 -0.03
Depreciation 0.01 0.00 0.00 0.01 0.03 0.03
Profit Before Tax -1.09 -0.74 -0.34 -0.19 -0.18 -0.06
Current Tax 0.00 0.00 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00
Reported Net Profit -1.09 -0.74 -0.34 -0.19 -0.18 -0.06
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit -1.09 -0.74 -0.34 -0.19 -0.18 -0.06
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward -5.86 -5.12 -4.78 -4.60 -4.42 -4.36
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -6.94 -5.86 -5.12 -4.78 -4.60 -4.42
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -0.46 -1.68 -0.77 -0.42 -0.41 -0.14
Earnings Per Share(Adj)-Unit Curr -0.46 -1.68 -0.77 -0.42 - -0.14
Book Value 10.40 -3.34 -1.67 -0.90 -0.47 -0.06
Book Value(Adj)-Unit Curr 10.40 -3.34 -1.67 -0.90 - -0.06

Shareholding Pattern

  • Public Share Holding

    100.00%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 0 0.00 0 0
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 761,938 3.21 675,638 41
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 570,533 2.41 570,533 29
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 805,830 3.40 805,630 90
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 15,314,292 64.60 15,289,092 178
Individuals holding nominal share capital up to Rs. 1 lakh 6,186,156 26.09 4,873,955 9,336
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 23,707,850 100.00 22,283,949 9,680
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 23,707,850 100.00 22,283,949 9,680

Company Background

Kabra Drugs LtdTrading

  • Kabra Drugs Ltd
  • BSE Code : 2908.0
  • ISIN : INE323K01017

  • Incorporation Year

    1989

  • Registered Office

    270 Shastri Market Indore
    , Indore,
    Madhya Pradesh-452007

  • Telephone

  • FAX

  • Chairman

  • Managing Director

  • Company Secretary

    Monika Sanwal

  • Auditor

    P P N AND COMPANY

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Ankit Consultancy Pvt Ltd
    Plot No. 60,
    Electronic Complex,Pardeshipura
    Mumbai - Indore - 452010

Kabra Drugs Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Kabra Drugs 20.65 0.64 0.00 6.45 0.00
Abbott India 25,586.10 7,217.19 6,929.05 33.67 43.78
Astrazeneca Phar 6,785.35 2,304.07 2,275.58 100.01 27.86
Glaxosmi. Pharma 2,837.20 3,932.76 3,790.20 45.32 58.17
Novartis India 2,393.15 393.10 354.33 60.43 15.94
Cipla 1,365.00 20,102.60 18,979.95 35.87 13.88
Bliss GVS Pharma 722.45 773.53 729.81 67.14 12.51
Amrutanjan Healt 490.35 520.13 502.55 26.26 24.16
Fermenta Biotec. 475.05 474.15 450.25 22.18 18.77
Guj. Themis Bio. 423.35 168.25 165.82 113.20 18.05
Ambalal Sarabhai 40.61 19.52 3.94 75.20 6.77